GL1X · GenesisL1 explorer

MolNFT v1 · #22094 · protein

Crystal structure of peptide deformylase from leptospira interrogans (lipdf) at PH7.5

1SV2: “Crystal structure of peptide deformylase from leptospira interrogans (lipdf) at PH7.5”. X-ray diffraction, 1 ligand (ZN), 5 pockets (best druggability 0.71). MolNFT v1 #22094 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
1SV2
Type
protein
Length
343 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peptide deformylase
EC
3.5.1.88
UniProt
Q93LE9
Ligands
ZN
Pockets
5 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeptide deformylase (EC 3.5.1.88)protein17126% helix, 30% strandQ93LE9
BPeptide deformylase (EC 3.5.1.88)protein17227% helix, 35% strandQ93LE9

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • DTT · 2,3-dihydroxy-1,4-dithiobutane · additive · 2 copies · chains A, B
  • FMT · Formic acid · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1590.710.9717DTT
2540.700.9716DTT
34220.600.7652empty
4930.350.7417empty
5660.290.7317empty

Interfaces

1 interface between chains.

  • A–B · 489 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 1SV2 · Crystal Structure of Peptide Deformylase from Leptospira Interrogans (LiPDF) at pH7.5 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q93LE9 · AlphaFold monomer V2.0 prediction for peptide deformylase (Q93LE9) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.